Why BrainChip (ASX:BRN) and Recce (ASX:RCE) shares just hit record highs

The BrainChip Holdings Ltd (ASX:BRN) share price and the Recce Pharmaceuticals Ltd (ASX:RCE) share price are on fire right now. Here's why…

| More on:
Chalk-drawn rocket shown blasting off into space

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market was on form on Tuesday and stormed notably higher again.

While a good number of shares climbed higher with the market, a few climbed more than most.

In fact, some climbed so much they reached new highs. Two which did exactly this are listed below. Here's why they are on fire right now:

BrainChip Holdings Ltd (ASX: BRN)

The BrainChip share price rocketed to a record high of 78 cents on Tuesday. Investors have been buying the artificial intelligence technology company's shares after it announced a collaboration with VORAGO Technologies at the start of the month. This collaboration could prove to be a very important one for BrainChip as it is intended to support a Phase 1 NASA program for a neuromorphic processor that meets spaceflight requirements.

Management believes its Akida neuromorphic processor is uniquely suited for spaceflight and aerospace applications. The device is a complete neural processor and does not require an external CPU, memory, or Deep Learning Accelerator. While I think BrainChip has some exciting technology, it still has a lot to prove. So with a market capitalisation of over $1.1 billion, I would suggest investors approach with caution.

Recce Pharmaceuticals Ltd (ASX: RCE)

The Recce share price stormed to a record high of $1.88 yesterday. Investors were fighting to get hold of the biotechnology company's shares after it provided an update on its international COVID-19 in vitro studies being undertaken by Path BioAnalytics and the University of Tennessee's Health Science Centre.

That update revealed that its Recce 327 (R327) and Recce 529 (R529) compounds have shown concentration-dependent reductions in the COVID-19 virus in an in-vitro study using organoids made from human airway epithelial cells. In light of this, researchers have recommended that the company advance research of both R327 and R529. Although this is very promising, management warned investors not to get too excited just yet. It commented: "Whilst Recce is delighted by the results, further testing must be completed before either (or both) compounds may be deemed safe or effective as a treatment of SARS-CoV-2."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Record Highs

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Technology Shares

Why is the Life360 share price rocketing 22% to a record high?

Records have been broken by this tech stock today.

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Record Highs

Happy Easter: ASX 200 hits another new record high

It's been a happy start to April for ASX 200 shares.

Read more »

A smiling woman puts fuel into her car at a petrol pump.
Energy Shares

How has this ASX 200 energy stock just hit another new record high?

This energy stock can't stop clocking new highs.

Read more »

ETF spelt out with a rising green arrow.

4 top ASX exchange-traded funds smashing record highs on Wednesday

If you own any of these popular ETFs, congratulations!

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Record Highs

ASX 200 soars to another new all-time high on Friday!

Exuberant investors just sent the ASX 200 to another new all-time high.

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
Share Market News

The ASX 200 just hit another new record high on Monday

The ASX 200 just breached Friday’s record to set a new all-time high today.

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Technology Shares

The Nasdaq just hit a fresh all-time high. What could it mean for Aussie investors?

With the Nasdaq at fresh highs, ASX tech shares are reaping the benefits.

Read more »

ETF written in gold with dollar signs on coin.

4 hot ASX ETFs smashing all-time highs on Thursday

ETFs are on fire this Thursday.

Read more »